Details of the Drug
General Information of Drug (ID: DMNC2A5)
| Drug Name |
Tosyl-D-Proline
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
TOSYL-D-PROLINE; TOS-D-PRO-OH; 110771-95-4; N-tosyl-D-proline; CHEMBL334226; TPR; (2R)-1-(4-methylphenyl)sulfonylpyrrolidine-2-carboxylic acid; 1f4e; AC1L9I3X; SCHEMBL2636629; ZINC63280; CTK8E6464; DTXSID60332192; CGPHGPCHVUSFFA-LLVKDONJSA-N; MolPort-014-930-952; BDBM50149243; 7792AH; AKOS006162662; DB02752; 1-[(4-methylphenyl)sulfonyl]-D-proline; AS-46804; D-Proline,1-[(4-methylphenyl)sulfonyl]-; D-Proline, 1-[(4-methylphenyl)sulfonyl]-; RT-016051; K-0696; (2R)-1-Tosylpyrrolidine-2beta-carboxylic acid; J-002477
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 269.32 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.6 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


